FDA Approves Immunotherapy That Can Spare Bladder Cancer Patients From Radical Surgery
ImmunityBio therapy Anktiva is now FDA approved for treating patients with non-muscle invasive bladder cancer. The novel immunotherapy works by sparking activity from three types of immune cells.
Don’t Let Inflation Bloat Your Drug Spending
Smart but easy tech upgrades can boost margins.
Collaboration Now: Maximizing AI’s Potential in the Industry it Matters Most
No passing fad, AI in healthcare is here, and it’s already improving the lives of patients, healthcare workers, and researchers. How can we make a good thing even better?
Neurodivergent Masking: A Hidden Contributor to the $2-Trillion Burnout Crisis
It can be tiring pretending to be someone you’re not. For many neurodivergent people at work, this is an everyday reality — and it’s burning them out.
Takeda, Astellas & Sumitomo Mitsui Form Joint Venture to Lift Japanese Innovation From ‘Valley of Death’
Two Japanese pharmaceutical companies and a bank are teaming up to form a joint venture to advance therapeutic discoveries from academia. The focus will be innovation from universities in Japan.